Navigation Links
Boss Panther Retractor

ProductsBoss Panther Retractor
Company Boss Instruments, Ltd.
Item Boss Panther Retractor
Features 
Description The Boss Panther Retractor is two system in one. Uncomplicated design and ease of use for all cervicle spine retraction objectives. Quick-connect angled blades of anodized aluminium facilitate soft tissue retraction and enhanced visualization. Aluminium blades allow for intra-operative imaging with minimal interference. Two retractor bodies, both longitudinal and transverse, provide for either anterior cervicle or microscopic lumbar procedures. Wide range of blade and hook styles accomodates a variety of patients and applications. Hand-held retraction handle is removable and assists in positioning of blades.
Info Boss Instruments, Ltd.
Customer Service: (800) 210-2677

Related medicine products :

1. Panther Universal Spinal Retractor System
2. The Panther Semi-dry Electroblotter - Model HEP-1 (Complete System)
3. The Panther Semi-dry Electroblotter - Model HEP-3 (Complete System)
4. Bloomberg Nucleus Rotator and Capsule Retractor
5. Stevenson Lacrimal Sac Retractor
6. Desmarres Lid Retractor
7. DesMarres Lid Retractor
8. Delicate Desmarres Lid Retractor
9. Desmarres Infant Retractor
10. Desmarres Retractor
11. Rigid Neck Rake Retractors
Fully lined with cotton material for extra softness against patients skin. The 3 single adjustable soft Velcro® band provides,downward pressure preventing implants from moving upward or to the s
Provides gentle compression above and below implants
Bandeau Bra
Compression Bra
Medicine Products:
(Date:9/5/2008)...G, Pa., Sept. 5 /PRNewswire-USNewswire/ -- Childre...r access to comprehensive,services to protect thei...n,in grants that were announced today by the Depar...vices for children and families, the department,be...ren,s Services Planning,initiative, ICSP, in 2004....
(Date:9/5/2008)..., Md., Sept. 5 /PRNewswire-USNewswire/ -- The Heal...day announced $39 million in grants to,increase an...centers., "These grants continue President Bush,s...whose services now reach more economically,vulnera...r before," HRSA,Administrator Elizabeth M. Duke sa...
(Date:9/5/2008)...ontrolled, but you need to know what triggers them...thDay News) -- If you are one of the 36 million Am...is nowhere in the United States that is free from ... shows. , Allergies don,t only happen in the sp...ell. In the fall, the most challenging cities to l...
(Date:9/5/2008)...N, Sept. 5 /PRNewswire-USNewswire/ -- Speaker Nanc...upport of the aims of the "Stand,Up to Cancer" tel...re is not a person in our country who has not seen...s 565,000 Americans annually, and each,year there ... must work,together to make eradicating the scourg...
Breaking Medicine News(10 mins):Health News:Pennsylvania Counties Receive Grants to Improve Services for Children 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:No Place Safe From Allergies 2
...extremely low frequency electromagnetic fields, su...ational and Environmental Medicine. The findings ...s, who were monitored for 30 years. The researche... group, because railway workers in Switzerland ten...
...] the BMA says it is extremely concerned at the gr... in law enforcement situations, in the belief tha...apons1, produced by the BMAs Board of Science, con...ver the right drug in the right dose to the right ...
...d the first human case of avian influenza since 20...alth has officially confirmed that a 29-year-old m...wo days after the suspected case was reported, acc... Agency. The man, from Vinh Phuc province, 60 kil...
...lleges staged protest here on Friday against Gover...hool. Moves to bring sex out of the closet have k...ay sex education will reduce number of HIV cases, ...t will corrupt young minds. Holding banners, plac...
Other Medicine News:Health News:Using Drugs as Weapons can Never Be 'non Lethal', Say Doctors 2
(Date:9/5/2008)...ates microRNAs Extracted From a Simple Blood Draw ...Biomarkers for a Wide Range of ...ology, Rosetta Genomics is Currently Developing ...cer, REHOVOT, Israel and JERSEY CITY, New Jersey,...omics, Ltd. (NASDQ: ROSG), a leader in,the develop...
(Date:9/4/2008)... in TaqMan(R) real-time PCR testing for the diagno...NTON, Calif., Sept. 4 /- The U.S. Foo...he COBAS(R) TaqMan(R) HBV Test,the first assay fo...he U.S.,The test uses Roche,s real-time PCR techno...NA in a patient,s blood. Doctors may use viral loa...
(Date:9/4/2008)... to Enroll 750 Women at More Than 100 Sites in the...QuatRx Pharmaceuticals, a,privately-held biopharma...cialization of compounds to treat endocrine, metab... that it has initiated a second,Phase 3 clinical t...ny,s,estrogen-free oral therapy in development for...
(Date:9/4/2008)...ng Patient Identification for Targeted Therapies ...reatment HUNTINGTON BEACH, Calif., and AMSTERDA... world leader in molecular cancer diagnostics,tod...iagnostic test that,allows physicians to quantitat...estrogen receptor (ER), progesterone receptor (PR)...
Breaking Medicine Technology:Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Agendia Launches TargetPrint(R) for Breast Cancer Patients 2The hand cant be fooled study shows 13893 1The hand cant be fooled study shows 13893 2Low levels of PYY hormone a very early indicator of type 2 diabetes 13889 1Low levels of PYY hormone a very early indicator of type 2 diabetes 13889 2Almost Family Announces Record Quarterly and Year End Results 13885 1Almost Family Announces Record Quarterly and Year End Results 13885 2Almost Family Announces Record Quarterly and Year End Results 13885 3Almost Family Announces Record Quarterly and Year End Results 13885 4Almost Family Announces Record Quarterly and Year End Results 13885 5Almost Family Announces Record Quarterly and Year End Results 13885 6Almost Family Announces Record Quarterly and Year End Results 13885 7Almost Family Announces Record Quarterly and Year End Results 13885 8Almost Family Announces Record Quarterly and Year End Results 13885 9Almost Family Announces Record Quarterly and Year End Results 13885 10Almost Family Announces Record Quarterly and Year End Results 13885 11A Communitys Fight to Preserve its Historical and Rural Culture in Virginia 3A Biotechnology CEO Gets Involved 3826 1
...-Apr 16, 2007 - Amgen,(Nasdaq:AMGN) today presente...cebo-controlled Phase 3 study evaluating the,effic...r the,treatment of anemia in patients with active ...("the 103 study"). Aranesp is not,approved for use...ts were presented in an oral session at the 2007 A...
... - Arsenic, a naturally,occurring element, has bee...rs, and even now remains a venerable constituent o...e in measure to the efforts of investigators suppo...rch Foundation,s,(SWCRF) "Institute Without Walls,...py for the treatment of certain types of acute,leu...
Other Medicine Technology:Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 2Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 3Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 4Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 5Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 6Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving,Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual,Meeting 7Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells 2Research Supported by Samuel Waxman Cancer Research Foundation,Discovers Mode of Action of Arsenic-Based Drugs in Destroying,Cancer Cells 3